Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 23-valent pneumococcal polysaccharide vaccine in healthy subjects ≥2 years
CTR20130165Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- May 2014
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease, sponsored by Beijing Minhai Biological. Started May 2014; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on CTR20130165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130165.